The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Vildagliptin Market Research Report 2025
Synopsis
White or off white crystalline powder,CAS no. is 274901-16-5 and molecular formula is C17H25N3O2.
The global Vildagliptin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Vildagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vildagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Vildagliptin include Hikal, Jubilant Pharma, Glenmark Life Sciences, Chengda Pharmaceuticals, Fuxin Longrui Pharmaceutical, Jiangxi Synergy Pharma, JSC Olainfarm, Century Pharmaceuticals and Metrochem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vildagliptin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vildagliptin.
Report Scope
The Vildagliptin market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vildagliptin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vildagliptin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hikal
Jubilant Pharma
Glenmark Life Sciences
Chengda Pharmaceuticals
Fuxin Longrui Pharmaceutical
Jiangxi Synergy Pharma
JSC Olainfarm
Century Pharmaceuticals
Metrochem
TAGOOR LABORATORIES
Biocon
Kimia Biosciences
Lee Pharma
Viwit
Shanghai Acebright
Ningbo Menovo Pharma
Hangzhou Longshine Bio-Tech
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Vildagliptin Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vildagliptin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Vildagliptin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Vildagliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
White or off white crystalline powder,CAS no. is 274901-16-5 and molecular formula is C17H25N3O2.
The global Vildagliptin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Vildagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Vildagliptin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Vildagliptin include Hikal, Jubilant Pharma, Glenmark Life Sciences, Chengda Pharmaceuticals, Fuxin Longrui Pharmaceutical, Jiangxi Synergy Pharma, JSC Olainfarm, Century Pharmaceuticals and Metrochem, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Vildagliptin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vildagliptin.
Report Scope
The Vildagliptin market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Vildagliptin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Vildagliptin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Hikal
Jubilant Pharma
Glenmark Life Sciences
Chengda Pharmaceuticals
Fuxin Longrui Pharmaceutical
Jiangxi Synergy Pharma
JSC Olainfarm
Century Pharmaceuticals
Metrochem
TAGOOR LABORATORIES
Biocon
Kimia Biosciences
Lee Pharma
Viwit
Shanghai Acebright
Ningbo Menovo Pharma
Hangzhou Longshine Bio-Tech
Segment by Type
Purity≥98%
Purity≥99%
Segment by Application
Vildagliptin Tablets
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Vildagliptin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Vildagliptin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Vildagliptin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Vildagliptin Market Overview
1.1 Product Definition
1.2 Vildagliptin Segment by Type
1.2.1 Global Vildagliptin Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Vildagliptin Segment by Application
1.3.1 Global Vildagliptin Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Vildagliptin Tablets
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Vildagliptin Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Vildagliptin Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Vildagliptin Production Estimates and Forecasts (2019-2030)
1.4.4 Global Vildagliptin Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Vildagliptin Production Market Share by Manufacturers (2019-2024)
2.2 Global Vildagliptin Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Vildagliptin, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Vildagliptin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Vildagliptin Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Vildagliptin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Vildagliptin, Product Offered and Application
2.8 Global Key Manufacturers of Vildagliptin, Date of Enter into This Industry
2.9 Vildagliptin Market Competitive Situation and Trends
2.9.1 Vildagliptin Market Concentration Rate
2.9.2 Global 5 and 10 Largest Vildagliptin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Vildagliptin Production by Region
3.1 Global Vildagliptin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Vildagliptin Production Value by Region (2019-2030)
3.2.1 Global Vildagliptin Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Vildagliptin by Region (2025-2030)
3.3 Global Vildagliptin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Vildagliptin Production by Region (2019-2030)
3.4.1 Global Vildagliptin Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Vildagliptin by Region (2025-2030)
3.5 Global Vildagliptin Market Price Analysis by Region (2019-2024)
3.6 Global Vildagliptin Production and Value, Year-over-Year Growth
3.6.1 North America Vildagliptin Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Vildagliptin Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Vildagliptin Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Vildagliptin Production Value Estimates and Forecasts (2019-2030)
4 Vildagliptin Consumption by Region
4.1 Global Vildagliptin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Vildagliptin Consumption by Region (2019-2030)
4.2.1 Global Vildagliptin Consumption by Region (2019-2024)
4.2.2 Global Vildagliptin Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Vildagliptin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Vildagliptin Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Vildagliptin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Vildagliptin Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Vildagliptin Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Vildagliptin Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Vildagliptin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Vildagliptin Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Vildagliptin Production by Type (2019-2030)
5.1.1 Global Vildagliptin Production by Type (2019-2024)
5.1.2 Global Vildagliptin Production by Type (2025-2030)
5.1.3 Global Vildagliptin Production Market Share by Type (2019-2030)
5.2 Global Vildagliptin Production Value by Type (2019-2030)
5.2.1 Global Vildagliptin Production Value by Type (2019-2024)
5.2.2 Global Vildagliptin Production Value by Type (2025-2030)
5.2.3 Global Vildagliptin Production Value Market Share by Type (2019-2030)
5.3 Global Vildagliptin Price by Type (2019-2030)
6 Segment by Application
6.1 Global Vildagliptin Production by Application (2019-2030)
6.1.1 Global Vildagliptin Production by Application (2019-2024)
6.1.2 Global Vildagliptin Production by Application (2025-2030)
6.1.3 Global Vildagliptin Production Market Share by Application (2019-2030)
6.2 Global Vildagliptin Production Value by Application (2019-2030)
6.2.1 Global Vildagliptin Production Value by Application (2019-2024)
6.2.2 Global Vildagliptin Production Value by Application (2025-2030)
6.2.3 Global Vildagliptin Production Value Market Share by Application (2019-2030)
6.3 Global Vildagliptin Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Hikal
7.1.1 Hikal Vildagliptin Corporation Information
7.1.2 Hikal Vildagliptin Product Portfolio
7.1.3 Hikal Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Hikal Main Business and Markets Served
7.1.5 Hikal Recent Developments/Updates
7.2 Jubilant Pharma
7.2.1 Jubilant Pharma Vildagliptin Corporation Information
7.2.2 Jubilant Pharma Vildagliptin Product Portfolio
7.2.3 Jubilant Pharma Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Jubilant Pharma Main Business and Markets Served
7.2.5 Jubilant Pharma Recent Developments/Updates
7.3 Glenmark Life Sciences
7.3.1 Glenmark Life Sciences Vildagliptin Corporation Information
7.3.2 Glenmark Life Sciences Vildagliptin Product Portfolio
7.3.3 Glenmark Life Sciences Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Glenmark Life Sciences Main Business and Markets Served
7.3.5 Glenmark Life Sciences Recent Developments/Updates
7.4 Chengda Pharmaceuticals
7.4.1 Chengda Pharmaceuticals Vildagliptin Corporation Information
7.4.2 Chengda Pharmaceuticals Vildagliptin Product Portfolio
7.4.3 Chengda Pharmaceuticals Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Chengda Pharmaceuticals Main Business and Markets Served
7.4.5 Chengda Pharmaceuticals Recent Developments/Updates
7.5 Fuxin Longrui Pharmaceutical
7.5.1 Fuxin Longrui Pharmaceutical Vildagliptin Corporation Information
7.5.2 Fuxin Longrui Pharmaceutical Vildagliptin Product Portfolio
7.5.3 Fuxin Longrui Pharmaceutical Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Fuxin Longrui Pharmaceutical Main Business and Markets Served
7.5.5 Fuxin Longrui Pharmaceutical Recent Developments/Updates
7.6 Jiangxi Synergy Pharma
7.6.1 Jiangxi Synergy Pharma Vildagliptin Corporation Information
7.6.2 Jiangxi Synergy Pharma Vildagliptin Product Portfolio
7.6.3 Jiangxi Synergy Pharma Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Jiangxi Synergy Pharma Main Business and Markets Served
7.6.5 Jiangxi Synergy Pharma Recent Developments/Updates
7.7 JSC Olainfarm
7.7.1 JSC Olainfarm Vildagliptin Corporation Information
7.7.2 JSC Olainfarm Vildagliptin Product Portfolio
7.7.3 JSC Olainfarm Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.7.4 JSC Olainfarm Main Business and Markets Served
7.7.5 JSC Olainfarm Recent Developments/Updates
7.8 Century Pharmaceuticals
7.8.1 Century Pharmaceuticals Vildagliptin Corporation Information
7.8.2 Century Pharmaceuticals Vildagliptin Product Portfolio
7.8.3 Century Pharmaceuticals Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Century Pharmaceuticals Main Business and Markets Served
7.7.5 Century Pharmaceuticals Recent Developments/Updates
7.9 Metrochem
7.9.1 Metrochem Vildagliptin Corporation Information
7.9.2 Metrochem Vildagliptin Product Portfolio
7.9.3 Metrochem Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Metrochem Main Business and Markets Served
7.9.5 Metrochem Recent Developments/Updates
7.10 TAGOOR LABORATORIES
7.10.1 TAGOOR LABORATORIES Vildagliptin Corporation Information
7.10.2 TAGOOR LABORATORIES Vildagliptin Product Portfolio
7.10.3 TAGOOR LABORATORIES Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.10.4 TAGOOR LABORATORIES Main Business and Markets Served
7.10.5 TAGOOR LABORATORIES Recent Developments/Updates
7.11 Biocon
7.11.1 Biocon Vildagliptin Corporation Information
7.11.2 Biocon Vildagliptin Product Portfolio
7.11.3 Biocon Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Biocon Main Business and Markets Served
7.11.5 Biocon Recent Developments/Updates
7.12 Kimia Biosciences
7.12.1 Kimia Biosciences Vildagliptin Corporation Information
7.12.2 Kimia Biosciences Vildagliptin Product Portfolio
7.12.3 Kimia Biosciences Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Kimia Biosciences Main Business and Markets Served
7.12.5 Kimia Biosciences Recent Developments/Updates
7.13 Lee Pharma
7.13.1 Lee Pharma Vildagliptin Corporation Information
7.13.2 Lee Pharma Vildagliptin Product Portfolio
7.13.3 Lee Pharma Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Lee Pharma Main Business and Markets Served
7.13.5 Lee Pharma Recent Developments/Updates
7.14 Viwit
7.14.1 Viwit Vildagliptin Corporation Information
7.14.2 Viwit Vildagliptin Product Portfolio
7.14.3 Viwit Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Viwit Main Business and Markets Served
7.14.5 Viwit Recent Developments/Updates
7.15 Shanghai Acebright
7.15.1 Shanghai Acebright Vildagliptin Corporation Information
7.15.2 Shanghai Acebright Vildagliptin Product Portfolio
7.15.3 Shanghai Acebright Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Shanghai Acebright Main Business and Markets Served
7.15.5 Shanghai Acebright Recent Developments/Updates
7.16 Ningbo Menovo Pharma
7.16.1 Ningbo Menovo Pharma Vildagliptin Corporation Information
7.16.2 Ningbo Menovo Pharma Vildagliptin Product Portfolio
7.16.3 Ningbo Menovo Pharma Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.16.4 Ningbo Menovo Pharma Main Business and Markets Served
7.16.5 Ningbo Menovo Pharma Recent Developments/Updates
7.17 Hangzhou Longshine Bio-Tech
7.17.1 Hangzhou Longshine Bio-Tech Vildagliptin Corporation Information
7.17.2 Hangzhou Longshine Bio-Tech Vildagliptin Product Portfolio
7.17.3 Hangzhou Longshine Bio-Tech Vildagliptin Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.17.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Vildagliptin Industry Chain Analysis
8.2 Vildagliptin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Vildagliptin Production Mode & Process
8.4 Vildagliptin Sales and Marketing
8.4.1 Vildagliptin Sales Channels
8.4.2 Vildagliptin Distributors
8.5 Vildagliptin Customers
9 Vildagliptin Market Dynamics
9.1 Vildagliptin Industry Trends
9.2 Vildagliptin Market Drivers
9.3 Vildagliptin Market Challenges
9.4 Vildagliptin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
